SARS-CoV-2 by Luban, Jeremy
University of Massachusetts Medical School 
eScholarship@UMMS 




University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/covid19 
 Part of the Immunology and Infectious Disease Commons, Infectious Disease Commons, Virology 
Commons, and the Virus Diseases Commons 
Repository Citation 
Luban J. (2020). SARS-CoV-2. COVID-19 Publications by UMMS Authors. https://doi.org/10.13028/
psdv-3088. Retrieved from https://escholarship.umassmed.edu/covid19/7 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in COVID-19 
Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, 






Wölfel, R., et al. (2020). Virological assessment of  9 hospitalized
patients with COVID-2019. Nature. in press
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None positive after day 8 or when viral load <106
Seroconversion
50% + by day 7; 100% by day 14
all had neutralizing abs
Sputum
average RNA load 7 x 106; max 2 x 109
83% virus positive in 1st week
Nasal swabs
average RNA load 7 x 105; max 7 x 108
17% virus positive in 1st week
Virus replication in upper respiratory tract
point mutation in swab vs sputum
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3′-nested subgenomic messenger RNAs (mRNAs). This last 
property has provided the name for the order, which comes 
from the Latin nido, for “nest”.157 It should be noted that the 
replicative similarities among the three nidovirus families are 
offset by marked differences in the numbers, types, and sizes 
of their structural proteins and great variation among the 
 morphologies of their virions and nucleocapsids.
Coronaviruses are now classified as one of two subfamilies 
(Coronavirinae) in the family Coronaviridae (see Fig. 28.1). 
The other subfamily, Torovirinae, includes the toroviruses, 
which are pathogens of cattle, horses, and swine,523 and the 
bafiniviruses, whose sole member is the only nidovirus cur-
rently known to infect fish.505 This chapter will concentrate 
almost exclusively on the Coronavirinae.
Coronaviruses have long been sorted into three groups, orig-
inally on the basis of serologic relationships and, subsequently, 
on the basis of phylogenetic clustering.193,195 Following propos-
als that were recently ratified by the International Committee 
on Taxonomy of Viruses (ICTV),57 these groups—the alpha-, 
beta-, and gammacoronaviruses—have now been accorded the 
taxonomic status of genera (see Fig. 28.1). The ICTV classifi-
cations have also established rigorous criteria for coronavirus 
species definitions, in a manner consistent with those used for 
other viral families. As a consequence, some viruses previously 
considered to be separate species are currently recognized as a 
single species—for example, the viruses now grouped within 
alphacoronavirus 1 or betacoronavirus 1 (Table 28.1). Addi-
tionally, the new classification criteria resolve any previous 
uncertainty about the taxonomic assignment of the virus that 
caused SARS (severe acute respiratory syndrome coronavirus 
[SARS-CoV]) as a betacoronavirus.153,197,374,473,483,521,534,535
Almost all alpha- and betacoronaviruses have mamma-
lian hosts. In contrast, the gammacoronaviruses, with a single 
exception, have been isolated from avian hosts. Several of the 
viruses listed in Table 28.1 have been studied for decades, spe-
cifically those included in the species alphacoronavirus 1, beta-
coronavirus 1, murine coronavirus, and avian coronavirus. The 
focus on these viruses came about largely because they were 
amenable to isolation and growth in tissue culture. However, 
since 2004, molecular surveillance and genomics efforts initi-
ated in the wake of the SARS epidemic have led to the discov-
ery of a multitude of previously unknown coronaviruses that 
now constitute most members of this subfamily.616 Notably, 
most of the newly recognized species were identified in bats, 
which constitute one of the largest orders within the mammals. 
Diverse coronaviruses have been described from bats, princi-
pally in Asia but also in Africa, Europe, and North and South 
America. These viruses include likely predecessors of SARS-
CoV308,332 but also four unique species of alphacoronaviruses 
and three species of betacoronaviruses. Birds have also proven 
to be a rich source of new viruses. Novel avian coronaviruses 
have been found to infect geese, pigeons, and ducks,255 and 
highly divergent coronaviruses recently identified in bulbuls, 
thrushes, and munias617 have the potential to define a fourth 
genus in the Coronavirinae. It has been proposed that bats and 
birds are ideally suited as reservoirs for the incubation and evo-
lution of coronaviruses, owing to their common ability to fly 
and their propensity to roost and flock.616
Five of the viruses in Table 28.1 are associated with human 
disease. The most categorically harmful of these, SARS-CoV, 
which is discussed at length later in this chapter, does not cur-
rently infect the human population. The remaining four human 
coronaviruses (HCoVs), the alphacoronaviruses HCoV-229E 
and HCoV-NL63, and the betacoronaviruses HCoV-OC43 
and HCoV-HKU1, typically cause common colds. Remark-
ably, HCoV-NL63 and HCoV-HKU1 were only discovered 
recently, in the post-SARS era,573,615 despite the fact that each 
has a worldwide prevalence and has been in circulation for 
a long time.461,618 Although generally associated with upper 
respiratory tract infections, the extant HCoVs can also cause 
lower respiratory tract infections and have more serious conse-
quences in the young, the elderly, and immunocompromised 
individuals. In particular, HCoV-NL63 is strongly associated 
with childhood croup,574 and the most severe HCoV-HKU1, 




Virions of coronaviruses are roughly spherical and exhibit a 
moderate degree of pleomorphism. In the earlier literature, 
viral particles were reported to have average diameters of 80 to 
120 nm but were far from uniform, with extreme sizes from 
50 to 200 nm.389 The spikes of coronaviruses, typically described 
as club-like or petal-shaped, emerge from the virion surface as 
stalks with bulb-like distal termini. Some of the variation in par-
ticle size and shape was likely attributable to stresses exerted by 
virion purification or distortions introduced by negative stain-
ing of samples for electron microscopy. More recent studies, 
employing cryo-electron microscopy and cryo-electron tom-
ography,21,30,413,415 have produced images (e.g., Fig. 28.2A) in 













FIGURE 28.1. Taxonomy of the order Nidovirales.
SARS-CoV-2 is a Beta-Coronavirus in the order Nidovirales
produce 3' co-terminal nested subgenomic mRNA's during infection
Where is SARS-CoV-2 within virus taxonomy?
jumping of the CoV within the large birds before the jump to
the small birds. Interestingly, the fact that PorCoV HKU15 and
SpCoV HKU17 are the same species implies that interspecies
jumping from birds to pigs may have occurred relatively re-
cently. It is possible that a deletion of 3= Ns7a and Ns7b had
occurred during interspecies jumping from birds to pigs, which
is similar to the observation of interspecies jumping of SARS-
CoV from civets to humans, with the deletion of 29 bp in ORF
FIG 5 Estimation of the time to the most recent common ancestor for Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus. The
time-scaled phylogeny was summarized from all MCMC phylogenies of the RdRp gene data set analyzed under the relaxed-clock model with an uncorrelated
log-normal distribution in BEAST version 1.6.1. Viruses characterized in this study are in bold. The numbers indicate number of years ago. This is shown in the
scale bar. Virus name abbreviations are the same as those in the legends of Fig. 1.
FIG 6 A model of CoV evolution. CoVs in bats are the gene source of Alphacoronavirus and Betacoronavirus, and CoVs in birds are the gene source of
Gammacoronavirus and Deltacoronavirus.
Woo et al.
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Which Coronaviruses infect humans?
SARS-CoV
Sarbecovirus subgenus
Are coronaviruses endemic among humans?
Why do they keep returning?
Weak immunity vs strain variants 
Up to 30% of  seasonal common cold
J Clin Virol 101:52




























Bats are the main reservoir
for SARS-like viruses
500 novel coronaviruses
in bats in China
50 in the SARS family 
Predicts future outbreaks
Pangolin ACE2 closer to 
human ACE2 than is bat 
ACE2
Critical residues in S protein 
are more similar between 
human and pangolin viruses
Overall, bat viruses closer 
to SARS-CoV-2 than are 
pangolin viruses













Some differences between SARS-CoV and SARS-CoV-2 
SARS-CoV SARS-CoV-2
8,096Cases 1,346,299 (166x)




severe cases and 1,114 deaths (WHO, 2020). Infections were
also detected in 24 countries outside China and were associated
with international travel. At present, it is unknown whether the
sequence similarities between SARS-CoV-2 and SARS-CoV
translate into similar biological properties, including pandemic
potential (Munster et al., 2020).
The spike (S) protein of coronaviruses facilitates viral entry into
target cells. Entry depends on binding of the surface unit, S1, of
the S protein to a cellular receptor, which facilitates viral attach-
ment to the surface of target cells. In addition, entry requires S
protein priming by cellular proteases, which entails S protein
cleavage at the S1/S2 and the S2’ site and allows fusion of viral
and cellular membranes, a process driven by the S2 subunit (Fig-
ure 1A). SARS-S engages angiotensin-converting enzyme 2
(ACE2) as the entry receptor (Li et al., 2003) and employs the
cellular serine protease TMPRSS2 for S protein priming (Glo-
wacka et al., 2011; Matsuyama et al., 2010; Shulla et al., 2011).
The SARS-S/ACE2 interface has been elucidated at the atomic
level, and the efficiency of ACE2 usage was found to be a key
determinant of SARS-CoV transmissibility (Li et al., 2005a,
2005b). SARS-S und SARS-2-S share !76% amino acid iden-
tity. However, it is unknown whether SARS-2-S like SARS-S em-
ploys ACE2 and TMPRSS2 for host cell entry.
RESULTS
Evidence for Efficient Proteolytic Processing
of SARS-2-S
The goal of our study was to obtain insights into how SARS-2-S
facilitates viral entry into target cells and how this process can be
Figure 1. SARS-2-S and SARS-S Facilitate Entry into a Similar Panel of Mammalian Cell Lines
(A) Schematic illustration of SARS-S including functional domains (RBD, receptor binding domain; RBM, receptor bindingmotif; TD, transmembrane domain) and
proteolytic cleavage sites (S1/S2, S20 ). Amino acid sequences around the two protease recognition sites (red) are indicated for SARS-S and SARS-2-S (asterisks
indicate conserved residues). Arrow heads indicate the cleavage site.
(B) Analysis of SARS-2-S expression (upper panel) and pseudotype incorporation (lower panel) by western blot using an antibody directed against the C-terminal
hemagglutinin (HA) tag added to the viral S proteins analyzed. Shown are representative blots from three experiments. b-Actin (cell lysates) and VSV-M (particles)
served as loading controls (M, matrix protein). Black arrow heads indicate bands corresponding to uncleaved S proteins (S0) whereas gray arrow heads indicate
bands corresponding to the S2 subunit.
(C) Cell lines of human and animal origin were inoculated with pseudotyped VSV harboring VSV-G, SARS-S, or SARS-2-S. At 16 h postinoculation, pseudotype
entry was analyzed by determining luciferase activity in cell lysates. Signals obtained for particles bearing no envelope protein were used for normalization. The
average of three independent experiments is shown. Error bars indicate SEM. Unprocessed data from a single experiment are presented in Figure S1.
2 Cell 181, 1–10, April 16, 2020
Please cite this article in press as: Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically
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Helical symmetry is common for negative-strand RNA virus 
nucleocapsids, although it is highly unusual for positive-strand 
RNA animal viruses, almost all of which have icosahedral cap-
sids. The best-resolved images of the coronavirus nucleocapsid, 
which were obtained with HCoV-229E, showed filamentous 
structures 9 to 13 nm in diameter, with 3- to 4-nm-wide 
central canals59; these filaments were thinner and less sharply 
segmented than paramyxovirus nucleocapsids. However, 
widely ranging and sometimes discrepant parameters have 
been reported for the nucleocapsids of other coronaviruses,378 
varying with both the viral species and the method of prepa-
ration.109,183,269,366,476 Thus, further work is needed to clearly 
define the diameter, symmetry, length, and protein: RNA stoi-
chiometry of this virion component in isolation. More recent 
coronavirus ultrastructural studies suggest that when packaged 
within the virion envelope, the helical nucleocapsid is quite 
flexible, forming coils and other structures that fold back on 
themselves.21,413
Virion Structural Proteins
Coronaviruses contain a canonical set of four major structural 
proteins: the spike (S), membrane (M), and envelope (E) pro-
teins, all of which are located in the membrane envelope, and 
the nucleocapsid (N) protein, which is found in the ribonu-
cleoprotein core (see Fig. 28.2B).
The distinctive surface spikes of coronaviruses are com-
posed of trimers of S molecules.30,129,529 S is a class I viral 
fusion protein41 that binds to host cell receptors and mediates 
the earliest steps of infection.95 In some cases, S protein can 
also induce cell–cell fusion late in infection. The S monomer 
is a transmembrane protein of 128 to 160 kDa, composed of 
a very large N-terminal ectodomain and a tiny C-terminal 
endodomain (Fig. 28.3). This protein is inserted, via a cleaved 
signal peptide,62 into the endoplasmic reticulum (ER), where 
it obtains N-linked glycosylation increasing its mass by some 
40 kDa.224,487 Comprehensive mapping of glycosylation sites 
has not been carried out for any S protein; however, an  analysis 
of the SARS-CoV S protein showed that at least half of its 
23 candidate sites are glycosylated.287 The early steps of glyco-
sylation occur co-translationally, and this modification assists 
monomer folding and proper oligomerization; terminal gly-
cosylation is then completed subsequent to trimerization.129 
S protein monomer folding is also accompanied by the forma-
tion of intramolecular disulfide bonds among a subset of the 
numerous cysteine residues of the ectodomain.425 The posi-
tions of S protein cysteines are well conserved in each corona-
virus genus2,153; disulfide linkages have yet to be mapped.
In many beta- and gammacoronaviruses (e.g., mouse hep-
atitis virus [MHV], bovine coronavirus [BCoV], and infectious 
bronchitis virus [IBV]), the S protein is partially or completely 
cleaved by a furin-like host cell protease into two polypeptides, 
denoted S1 and S2, which are roughly equal in size. Corre-
spondingly, in coronaviruses that do not have detectably cleaved 
mature S proteins, the N-terminal and C-terminal halves of the 
molecule are also designated S1 and S2, respectively. S protein 
cleavage occurs immediately downstream of a highly basic pen-
tapeptide motif,2,62,361 and the extent of proteolysis correlates 
with the number of positively charged residues in the motif.36 
The S1 domain is extremely variable, exhibiting very low 
homology across the three genera and often diverging exten-
sively among different isolates of a single  coronavirus.181,430,597 
By contrast, the S2 domain is highly conserved.111 For those 
coronaviruses in which it occurs, S1-S2 cleavage is a late event 
in virion assembly and release from infected cells. For many 
other coronaviruses, an alternative type of S protein cleavage 
(S2′) takes place during the initiation of infection, activating 
the molecule for fusion.28 The differing functions of S1 and 
S2 and the role of proteolysis are discussed later (see the Viral 
Entry and Uncoating section).
A complete high-resolution structure has not yet been 
determined for any coronavirus S protein, although a cryo-
electron microscopic reconstruction of the SARS-CoV S 
protein is available,30 and partial crystal structures have been 







FIGURE 28.2. Coronavirus structure. A: Cryo-electron tomographic image of purified virions of mouse hepatitis virus (MHV), recon-
structed as described in reference 415. (Courtesy of Benjamin Neuman, David Bhella, and Stanley Sawicki.) B: Schematic showing the 
major structural proteins of the coronavirus virion: S, spike protein; M, membrane protein; E, envelope protein; and N, nucleocapsid protein.
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 transcribed in vivo by fowlpox-encoded T7 RNA polymerase.58 
Collectively, these systems developed for complete reverse 
genetics provide an important pathway toward unraveling the 
complexities of the coronavirus replicase.
CORONAVIRUS REPLICATION
Virion Attachment to Host Cells
Coronavirus infections are initiated by the binding of virions 
to cellular receptors (Fig. 28.6). There then follows a series of 
events culminating in the delivery of the nucleocapsid to the 
cytoplasm, where the viral genome becomes available for trans-
lation. Individual coronaviruses usually infect only one or a 
few closely related hosts. The interaction between the viral S 
protein and its cognate receptor constitutes the principal deter-
minant governing coronavirus host species range and tissue 
tropism. This has been most convincingly shown in two ways. 
First, the expression of a particular receptor in nonpermissive 
cells of a heterologous species renders those cells permissive for 
the corresponding coronavirus.127,146,330,331,399,567,639 Second, the 
engineered replacement of the S protein ectodomain changes 
the host cell species specificity or tissue tropism of a coronavi-
rus in a predictable fashion.207,292,410,453,495 The amino- terminal, 
more variable half of the spike protein, S1, is the part that 
binds to receptor. Binding leads to conformational changes 
that result in fusion between virion and cell membranes, medi-
ated by the more conserved half of the spike protein, S2. The 
region of S1 that contacts the receptor—the receptor-binding 
domain (RBD)—varies among different coronaviruses (see 
Fig. 28.3). For MHV, the RBD maps to the N-terminal section 
of S1.290,554 By contrast, RBDs for SARS-CoV,614,625 HCoV-
NL63,337 transmissible gastroenteritis virus (TGEV),188 and 
HCoV-229E34 fall in the middle or C-terminal sections of S1.
The known cellular receptors for alpha- and betacoro-
naviruses are listed in Table 28.2; to date, no receptors have 
been identified for gammacoronaviruses. The MHV receptor 
mCEACAM1 was the first discovered coronavirus receptor (as 
well as one of the first receptors defined for any virus).606,607 
That this molecule is the only biologically relevant receptor for 
MHV was made clear by the demonstration that homozygous 
Ceacam1−/− knockout mice are totally resistant to infection by 
high doses of MHV.215 CEACAM1 is a member of the carci-
noembryonic antigen (CEA) family within the immunoglobu-
lin (Ig) superfamily and, in its full-length form, contains four 
Ig-like domains.146 A diversity of two- and four-Ig domain iso-
forms is generated by multiple alleles and alternative splicing 
variants of Ceacam1.97,145,147,422,423,641 The wide range of patho-
genicity of MHV in mice is thought to be strongly affected by 
the interactions of S proteins of different virus strains with the 
array of receptor isoforms that are expressed in mice of differ-
ent genetic backgrounds. Although their S proteins are phylo-
genetically very close to that of MHV, the betacoronaviruses 
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SARS-CoV-2 has an amazing set of  proteins
Antagonists of the immune system (e.g., 2’-O-MTase; nsp16)
RNA replication machinery (RdRP; nsp12)
Replication proof-reading (3’-5’ exonuclease; nsp14)
RNA metaboblism in the cytoplasm (7-methyltransferase; nsp14)
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of nsp14.395 This enzyme is not essential for viral replication; 
however, nsp14 mutants have a greatly enhanced mutation 
rate, supporting the notion that ExoN provides a proofread-
ing function for the coronavirus RdRp.149,150 Such a corrective 
activity may be critical for maintenance of the stability of the 
exceptionally large coronavirus genome.
Viral RNA Synthesis
Expression and assembly of the RTC sets the stage for viral 
RNA synthesis (see Fig. 28.6), a process resulting in the rep-
lication of genomic RNA and the transcription of multiple 
subgenomic RNAs (sgRNAs).299,433,577 The latter species serve 
as mRNAs for the genes downstream of the replicase gene. 
Each sgRNA consists of a leader RNA of 70 to 100 nucle-
otides, which is identical to the 5′ end of the genome, joined 
to a body RNA, which is identical to a segment of the 3′ end 
of the genome. The fusion of the leader RNA to body RNAs 
occurs at short motifs—TRSs—examples of which are listed in 
Figure 28.9. Like the genome, the sgRNAs have 5′ caps and 3′ 
polyadenylate tails. Together, these transcripts form a 3′-nested 
set—the single most distinctive feature of the order Nidovi-
rales.157,194 Synthesis of both genomic RNA and sgRNAs pro-
ceeds through negative-strand intermediates.24,509 The negative 
sense RNAs, which possess 5′ oligouridylate tracts220 and 3′ 
antileaders,508 are roughly a tenth to a hundredth as abundant 
as their positive sense counterparts.
At their 5′ and 3′ termini, coronavirus genomes contain 
cis-acting RNA elements that allow their selective recogni-
tion as templates for the RTC and play essential roles in RNA 
synthesis (see Fig. 28.9). The initial localization of these ele-
ments was carried out in studies of defective interfering (DI) 
RNAs, which are extensively deleted genomic variants that 
propagate by competing for the viral RNA synthesis machin-
ery.69,371,393,445,575 Manipulations of natural and artificially 
constructed DI RNAs, evaluated by transfection into helper-


































MHV, BCoV, HCoV-HKU1 5’-AAUCUAAAC-3’
SARS-CoV 5’-AAACGAAC-3’
TGEV, FIPV, HCoV-NL63 5’-AACUAAAC-3’α-CoV
IBV 5’-CUUAACAA-3’γ-CoV
β-CoV
FIGURE 28.9. Coronavirus RNA synthesis. Shown are a schematic of MHV genomic RNA and the nested set of transcribed 
subgenomic RNA species that are a defining feature of the order Nidovirales. The leader and body copies of the TRS (TRS-L and 
TRS-B, respectively) are denoted by green boxes. At the left are listed examples of consensus TRSs that have been experimentally 
confirmed462,463,531,562; the inferred TRSs of other coronaviruses are identical or highly similar to these. Expanded regions above the 
genome depict cis-acting RNA structures at the genome termini. The structures shown are those characterized for MHV.190,202,346,667 
Homologous structures exist in the BCoV53,622 and SARS-CoV genomes,192,261 and counterparts of some of these elements appear 
in other coronaviruses.80,107,605 The 5′ expanded region represents the 210-nt 5′ UTR and the first 140 nt of the rep 1a gene; the 
elements shown are SLs I through VI, numbered as originally described for BCoV.53,202 TRS-L is denoted in green in SL II; the start 
codon of rep 1a is boxed in SL IV. The 3′ expanded region represents the 301-nt 3′ UTR. The elements shown are the bulged stem 
loop (BSL), the pseudoknot (PK ), the hypervariable region (HVR ), and the conserved coronavirus octanucleotide motif (oct); the 
stop codon for the upstream N gene is boxed. MHV, mouse hepatitis virus; TRS, transcription-regulating sequence; BCoV, bovine 
coronavirus; SARS-CoV, severe acute respiratory syndrome coronavirus; UTR, untranslated region; nt, nucleotide; SL, stem loop.
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highest rate observed for any RNA virus.22 On a fine scale, the 
sites of crossover are random,19 although selective pressures can 
generate the appearance of local clustering of recombinational 
hot spots.18 This facility for RdRp strand switching may make 
a major contribution to the ability of the huge coronavirus 
genome to evolve and to circumvent the accumulation of del-
eterious mutations. It also serves as the basis for targeted RNA 
recombination (see the Coronavirus Genetics section).
Assembly and Release of Virions
The immediate outcome of transcription is to enable trans-
lation of the proteins that build progeny viruses. The 
 membrane-bound proteins M, S, and E are initially inserted 
into the ER; from there, they transit to the site of virion assem-
bly, the endoplasmic reticulum–Golgi intermediate compart-
ment (ERGIC).275,285,563 Here, nucleocapsids composed of 
progeny genomes encapsidated by N protein coalesce with 
the envelope components to form virions, which bud into the 
ERGIC117,222,378 (see Fig. 28.6).
Coronavirus assembly occurs through a network of coop-
erative interactions, most of which involve M protein. How-
ever, despite its central role, M is not assembly competent by 
itself. Expression of M protein alone does not result in virion-
like structures, and M traverses the secretory pathway beyond 
the budding site, as far as the trans-Golgi.275,362,363,489 The first 
virus-like particle (VLP) systems developed for coronaviruses 
led to the key finding that co-expression of E protein with M 
protein is sufficient to yield the formation of particles that are 
released from cells and appear morphologically identical to 
coronavirus envelopes.37,582 More recently, it has been shown 
that the additional co-expression of N protein substantially 
increases the efficiency of VLP formation38,519 and can even 
compensate for mutational defects in M.15 Other viral struc-
tural proteins, in particular S protein, are gathered into viri-
ons but are not specifically required for the assembly process. 
Because virions and VLPs contain very little E protein, this 
indicates that lateral interactions between M molecules pro-
vide the driving force for envelope morphogenesis. Investi-
gations of the ability of M protein mutants to support VLP 
assembly concluded that M–M interactions occur via multi-
ple contacts throughout the molecule, especially between the 
transmembrane domains.114,120 Recent cryo-electron tomo-
graphic reconstructions of whole virions suggest that the M 
protein forms dimers that are maintained through multiple 
monomer– monomer contacts, while dimer–dimer interactions 
occur among the globular endodomains.415
It remains enigmatic how E protein critically assists M 
in envelope formation. Like M, E protein by itself moves to 
a compartment past the ERGIC93,100; however, co-expression 






























FIGURE 28.10. Coronavirus transcription through discontinuous extension of negative-strand RNA synthesis.496,498,664 A, 
B: Negative-strand sgRNA synthesis initiates at the 3′ end of the positive-strand genomic RNA template. In the version of the model 
shown here, the genomic template loops out in such a way as to allow a component of the RTC to constantly monitor the potential 
complementarity of the 3′ end of the nascent negative-strand RNA with the TRS-L. C: Transcription pauses at a TRS-B. At this point, 
elongation may resume, thereby bypassing the TRS-B. D: Alternatively, the nascent negative strand may switch templates, binding 
to the TRS-L. E: Resumption of elongation results in completion of synthesis of an antileader-containing negative-strand sgRNA.
F: The resulting complex of genome and negative-strand sgRNA acts as template for the synthesis of multiple copies of the cor-
responding positive-strand sgRNA. sgRNA, subgenomic RNA; RTC, replicase-transcriptase complex; TRS, transcription-regulating 
sequence. (Adapted from Zúñiga S, Sola I, Alonso S, et al. Sequence motifs involved in the regulation of discontinuous coronavirus 
subgenomic RNA synthesis. J Virol 2004;78:980–994.)
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